Our previous study demonstrated that butyric acid, an extracellular metabolite of periodontopathic bacteria, induced apoptosis in murine thymocytes, splenic T cells, and human Jurkat cells. In this study, we examined whether CD95 ligand-receptor interaction is involved in butyric acid-induced T-cell apoptosis. Flow cytometry analysis indicated that expression of Fas in Jurkat and T cells from peripheral blood mononuclear cells was not affected by butyric acid treatment. Furthermore, the expression of Fas and FasL protein in Western blotting was not affected by butyric acid treatment. Coincubation with blocking anti-Fas antibodies prevented Fas-induced apoptosis but not butyric acid-induced apoptosis. Anti-FasL antibodies also did not prevent butyric acid-induced apoptosis at any dose examined. Although cytotoxic anti-Fas antibody affected butyric acid-induced apoptosis, a synergistic effect was not seen. Time-dependent activation of caspase-8 and -9 was recognized in butyric acid-as well as Fas-mediated apoptosis. IETD-CHO and LEHD-CHO, specific inhibitors of caspase-8 and -9, respectively, completely blocked Fas-mediated apoptosis and partially prevented butyric acid-induced apoptosis. These results suggest that the Fas-FasL interaction is not involved in butyric acidinduced apoptosis and that caspase-8 and -9-dependent apoptosis plays an important role in butyric acidinduced apoptosis, as well as Fas-induced apoptosis.
Mch-4) (4, 11) . The recruitment of these proteases induces their autocatalytic processing and activation, which finally leads to the cleavage and activation of caspase-3, the apoptotic executioner. Recently, it was proposed that butyrate can induce apoptosis in human cancer cells (5) and mouse colonic cells (10) via the Fas-FasL system. Activation of caspases is also a key event during the intermediate and terminal phases of apoptosis (30) . Caspases implicated in apoptosis are currently divided into activator caspases and effector caspases. The activator caspases currently include caspase-8, -9, and -10, whereas caspase-3, -6, and -7 execute the final cell death. The involvement of individual activator or effector caspases in butyric acid-induced cell death and their exact order within the apoptotic cascade are not known in detail.
The aim of this study was to determine whether butyric acid requires the Fas-FasL system or caspase-8 and -9 activation to induce T cell death in vitro. Our findings indicate that caspase-8 and -9-dependent apoptosis plays an important role in butyric acid-induced T-cell death but is independent of the Fas-FasL interaction.
MATERIALS AND METHODS
Reagents. Highly purified butyric acid was purchased from Sigma Chemical Co. (St. Louis, Mo.). Solutions of butyric acid ranging in concentration from 0.62 to 5 mM were diluted in RPMI 1640 (Gibco Laboratories, Grand Island, N.Y.) medium and adjusted to pH 7.2 with sodium hydroxide. Cytotoxic anti-human Fas immunoglobulin (IgM) monoclonal antibody (MAb) (clone CH-11), noncytotoxic blocking mouse anti-human Fas IgG MAb (clone ZB4), and noncytotoxic blocking hamster anti-human FasL IgG MAb (clone 4H9) were from MBL Co. (Nagoya, Japan).
T-cell preparation. Peripheral blood mononuclear cells (PBMC) were separated from the heparinized venous blood of healthy adults by Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden) gradient centrifugation. T cells were then separated from PBMC by immunomagnetic cell sorting. PBMC were incubated for 45 min at 4°C with a mixture of MAbs to CD14, CD16, CD19, and CD56 (Stemcell Technologies, Vancouver, Canada). The cells were then washed, and antibody-loaded cells were depleted by negative magnetic selection using antimouse IgG-coated magnetic beads (Dynal, Oslo, Norway). T cells isolated in this fashion were typically Ͼ98% CD3 ϩ cells as analyzed by flow cytometry (Becton Dickinson, San Jose, Calif.). The human T-lymphoma cell line Jurkat was kindly provided by Fujisaki Cell Center-Hayashibara (Okayama, Japan). These cells were cultured at 37°C in a moist 5% CO 2 atmosphere in complete medium consisting of RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 U of penicillin per ml, 100 g of streptomycin per ml, and 0.05 mM 2-mercaptoethanol.
Cell proliferation assay. Jurkat T cells (2 ϫ 10 6 cells/ml) were treated in complete medium with either 1.25 or 2.5 mM butyric acid or cytotoxic anti-Fas MAb (CH-11 [10 ng/ml]) in flat-bottomed, 96-well plates (100 l/well). For apoptosis inhibition assays, cells were preincubated for 1 h with blocking anti-Fas MAb (ZB4) (1 to 100 g/ml), with blocking anti-FasL MAb (4H9) (1 to 100 g/ml), or with their isotype controls (mouse IgG1 and hamster IgG; Southern Biotechnology Associates Inc., Birmingham, Ala.) before adding butyric acid or cytotoxic anti-Fas MAb (CH-11). After incubation for 42 h, 20 l of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT) (5 mg/ml in phosphate-buffered saline [pH 7.2; Sigma]) was added to each well. After 6 h of incubation, the supernatants were decanted, and the formazan precipitates were solubilized by the addition of 150 l of 100% dimethyl sulfoxide (Sigma) and placed on a plate shaker for 10 min. Absorbance at 550 nm was determined on an MT32 spectrophotometric microplate reader (Corona Electric Co., Ibaraki, Japan). The absorbance and the standard error of the mean (SEM) were calculated for every concentration of butyric acid tested.
T-cell culture for apoptosis. Jurkat cells (10 6 per well) were cultured in 1 ml of complete medium in 24-well tissue culture plates (Falcon; Becton Dickinson Labware, Lincoln Park, N.J.) with various concentrations of butyric acid, in the presence or absence of anti-Fas MAb (CH-11 [10 ng/ml]). After incubation for 21 h, the cells were harvested, centrifuged at 400 ϫ g for 5 min, and washed twice with ice-cold PBS. The cells were resuspended in 400 l of hypotonic lysis buffer (0.2% Triton X-100, 10 mM Tris, 1 mM EDTA [pH 8.0]) and centrifuged for 15 min at 13,800 ϫ g (26) . Half the supernatants, which contained small DNA fragments, as well as the pellet containing large pieces of DNA and cell debris, were used for the diphenylamine (DPA) assay (see below).
DNA fragmentation assay. The DPA reaction was performed by the method of Paradones et al. (29) . Perchloric acid (0.5 M) was added to the other half of the DNA (resuspended with 200 l of hypotonic lysis buffer) and to the pellets containing uncut the supernatants containing DNA fragments, and then 2 volumes of a solution containing 0.088 M DPA, 98% (vol/vol) glacial acetic acid, 1.5% (vol/vol) sulfuric acid, and a 0.5% (vol/vol) concentration of 1.6% acetaldehyde solution were added. The samples were stored at 4°C for 48 h. The colorimetric reaction was quantified spectrophotometrically at 575 nm with a model UV-160A UV spectrophotometer (Shimazu Co. Ltd., Tokyo, Japan). The percentage of fragmentation was calculated as the ratio of DNA in the supernatants to the total DNA.
Flow cytometry analysis. PBMC (4 ϫ 10
6
) and Jurkat cells (1 ϫ 10 6 ) in 1 ml of medium were cultured for the indicated times with or without 5 mM butyric acid. To measure Fas expression, cells (10 6 ) were then harvested and stained with fluorescein isothiocyanate-labeled anti-human Fas MAb (clone DX2) or with an isotype control (mouse IgG1) (Becton Dickinson) for 30 min at 4°C. After washing in PBS, the samples were analyzed with a FACScan apparatus within 1 h. Data from 10 6 cells were analyzed for each sample. Western blotting. Cells were lysed in lysis buffer (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM EGTA, 0.1 mM phenylmethylsulfonyl fluoride, 8 g of aprotinin per ml, 2 g of leupeptin per ml) and centrifuged at 14,000 ϫ g for 10 min at 4°C. The supernatant was collected and the amount of protein was measured using the Bio-Rad (Hercules, Calif.) protein assay. Equal amounts (25 g) of protein from each sample were separated by sodium dodecyl sulfate-12.5% polyacrylamide gel electrophoresis and transferred to a polyvinylfluoride membrane (Millipore, Bedford, Mass.). Western blots were probed with mouse anti-human Fas or FasL MAbs, or with their isotype controls (mouse IgG1) obtained from Transduction Laboratories (Lexington, Ky.). Primary antibodies were detected using a goat-anti mouse horseradish peroxidase-conjugated secondary antibody (Amersham, Little Chalfont, United Kingdom). Detection of chemiluminescence was performed with an ECL Western blot detection kit (Amersham), according to the supplier's recommendations.
Measurement of caspase protease activity. After incubation of cells (10 6 per well) in 24-well tissue culture plates for the indicated times with 5 mM butyric acid or 10 ng of cytotoxic anti-Fas MAb (CH-11) per ml, all the cells were collected, washed as described above, and the caspase-8 and -9 activities were measured using a caspase fluorometric protease assay kit (MBL Co.). Levels of released 7-amino-4-trifluoromethylcoumarin (AFC) were measured with a BioLumin 960 spectrofluorometer (Molecular Dynamics Japan, Tokyo, Japan) with excitation at 400 nm and emission at 505 nm. The results are expressed as the mean Ϯ SEM of three different experiments with triplicate cultures. Values significantly different from the corresponding negative control without stimulants, or the corresponding inhibitor-free anti-Fas antibody or butyric acid values at P Ͻ 0.05 are indicated. Inhibition of caspase-8 with IETD-cleaving activity and of caspase-9 with LEHD-cleaving activity was achieved using caspase-8 inhibitor Ac-IETD-CHO and caspase-9 inhibitor Ac-LEHD-CHO (Peptide Institute, Inc., Osaka, Japan), respectively, administered 1 h before the addition of butyric acid or anti-Fas antibody.
Statistics. Multiple-group comparisons were made using a one-way analysis of variance followed by post hoc intergroup comparison by the Bonferroni-Dunn test. Where appropriate, Student's t test was used to compare two groups.
RESULTS

Expression of Fas in Jurkat and PBMC-T cells after butyric acid treatment.
To test whether the Fas-FasL system might mediate butyric acid-induced apoptosis, Jurkat and T cells from PBMC (PBMC-T cells) were cultured for the indicated times with 5 mM butyric acid, and Fas expression was assessed by flow cytometry (Fig. 1) . Jurkat cells endogenously express Fas on their surface, and Fas expression was not affected by 6 or 16 h butyric acid treatment (Fig. 1A) . Although normal peripheral blood T cells express substantial amounts of Fas (Fig. 1B) and upregulate its expression within 16 h of treatment with anti-CD3 MAb (data not shown), the expression was not affected by butyric acid treatment (Fig. 1B) . These results indicate that Fas expression is not associated with butyric acidinduced apoptosis. Furthermore, we analyzed the effect of butyric acid on Fas and FasL protein expressions in Jurkat cells by Western blotting (Fig. 2) . Jurkat cells constitutively expressed Fas and FasL proteins, and this expression was not affected by butyric acid treatment.
Effect of anti-Fas or anti-FasL MAbs on butyric acid-induced apoptosis. It was recently proposed that the Fas-FasL system is involved in the cytotoxicity exerted by several drugs, including butyric acid (10, 23) . To test this hypothesis, apoptosis was induced in Jurkat cells by treatment with butyric acid in the presence or absence of different concentrations of blocking anti-Fas MAb (ZB4 [1 to 100 g/ml]). To assess the blocking activity of this antibody, cells were also treated with a cytotoxic anti-Fas IgM MAb (CH-11 [10 ng/ml]). After 24 h of incubation, cell viability was determined by the MTT assay. As shown in Fig. 3 , while all the cytotoxicity induced by CH-11 antibody was prevented by the blocking antibody in a dose-dependent manner, there was no inhibition of butyric acid-induced cell death.
We next tested whether the FasL system, which is the main mediator of activation-induced cell death in Jurkat T cells (22) , could be involved in the butyric acid-induced apoptosis. Jurkat cells were cultured with butyric acid in the presence or absence of different concentrations of anti-FasL MAb (4H9 [1 to 100 g/ml]) and examined for cell viability (Fig. 4) . Anti-FasL MAb did not prevent butyric acid-induced apoptosis at any dose examined. Activation of caspase-8 and -9 in butyric acid-induced and cytotoxic anti-Fas-induced apoptosis. There is growing evidence suggesting that activator caspases, especially caspase-8 and -9, play essential roles in the apoptotic process. The requirement for caspase-8 and -9 in Fas-and butyric acid-induced apoptosis was determined by their capacity to cleave the caspase-8 substrate IETD-AFC and the caspase-9 substrate LEHD-AFC. Analysis of protease activation during the cell death induced by treatment of Jurkat cells with cytotoxic antiFas (CH-11) MAb or with butyric acid resulted in a timedependent increase in caspase-8 and -9 protease activities ( Fig.  6A and B) . The increase in caspase-8 protease activity began about 6 h after the addition of anti-Fas (CH-11) MAb and peaked after 16 to 21 h, reaching levels more than three times those of control populations. Treatment with butyric acid also increased caspase-8 activity time-dependently, although the increase was slight (1.8-fold) compared with anti-Fas treatment. The increase in caspase-9 protease activity also began about 6 h after the addition of anti-Fas (CH-11) MAb and peaked after 21 h, reaching levels more than four times those of the control. Treatment with butyric acid also increased caspase-9 activity about 16 h after its addition. The enhanced caspase-8 proteolytic activity induced by treatment of Jurkat cells with anti-Fas MAb or butyric acid was inhibited to below the control levels in a dose-dependent manner by treatment with the caspase-8 inhibitor IETD-FMK, indicating that IETD-FMK inhibits the activation of caspase-8 protease induced by anti-Fas MAb or butyric acid (Fig. 6C) . Pretreatment with the caspase-9 inhibitor LEHD-FMC also decreased butyric acid-induced and Fas-induced caspase-9 activity to near the control levels (Fig. 6D) . However, IETD-FMK and LEHD-FMC, which completely block Fas-mediated apoptosis, partially prevented butyric acid-induced apoptosis (Fig. 6E and  F) .
DISCUSSION
Since the Fas-FasL system plays a major role in the homeostasis of the immune system (7) and because lymphocytes are exquisitely sensitive to butyric acid (17, 18) , we tested whether the lymphocytic response to butyric acid is involved the Fas-FasL system. Fas expression can be induced in response to various cytokines, including gamma interferon and tumor necrosis factor alpha (21, 32) , to wild-type p53 activity (28) and to cytotoxic drugs (23, 24) . In contrast, alkyl-isophospholipids (8), doxorubicin (12) , and hydrogen peroxide (9) induce apoptosis independently of Fas signaling.
In the present study we have demonstrated that Fas and FasL expression does not involve butyric acid-induced apoptosis ( Fig. 1 and 2) . Coincubation with blocking anti-Fas or anti-FasL MAbs could not prevent butyric acid-induced apoptosis ( Fig. 3 and 4) . In addition, PBMC-T cells, which express membrane Fas (Fig. 1) but are resistant to Fas-mediated apoptosis, were efficiently killed by butyric acid (17) . Therefore, in spite of the presence or absence of functional Fas, it can be concluded that butyric acid-induced apoptosis occurs independently of activation of the Fas-FasL system since no correlation between sensitivity to Fas and butyric acid was found. There- fore, cytotoxic anti-Fas MAb also affected butyric acid-induced apoptosis, but no synergistic effect was seen (Fig. 5) .
Caspase activation plays a central role in the execution of apoptosis. The two best-studied pathways of caspase activation are the cell surface death receptor pathway, such as Fas-mediated apoptosis, and the mitochondrion-initiated pathway (6) . In this study, time-dependent activation of caspase-8 and -9 was recognized in butyric acid-as well as Fas-mediated apoptosis. These data show for the first time that butyric acid activates a key element of the Fas signaling pathway independently of Fas/FADD activation. Hence, the expression of FasL or activation of Fas is not essential for the initial triggering of the apoptotic cascade by butyric acid. Although the precise mechanism of butyric acid-induced apoptosis remains unclear, our previous study indicated that butyric acid treatment decreased Bcl-2 and Bcl-XL expression in murine splenic T cells (unpublished data). The Bcl-2 family regulates apoptosis via the release of cytochrome c from mitochondria (16) . The upregulation of anti-apoptotic Bcl-2 or its close homologue Bcl-XL is known to inhibit apoptosis (3), whereas the downregulation of Bcl-2 or its antagonization by dimerization with Bax-␣ promotes programmed cell death (27) . This indicates that the butyric acid-induced pathway is closely involved with the mitochondrial Bcl-pathway, known to be critical to apoptosis in other models (15, 25) . Sodium butyrate is reported to decrease the Bcl-2 level, whereas it increases the Bax level and stimulates the release of cytochrome c from the mitochondria in human retinoblastoma cells (13) . Therefore, in butyric acidinduced apoptosis, undefined signals seem to lead to perturbation of mitochondria and loss of cytochrome c and then activation of caspases. In the cytochrome c-initiated caspase cascade, hierarchical activation of caspase-2, -3, -6, -7, -8, and -10 occurs in a caspase-9-dependent manner (31) . It has also been proposed that caspase-8 can be activated not only by death receptor signaling but also by cytochrome c translocation (2). In our study, caspase-8 and -9 inhibitors did not inhibit the T-cell apoptosis induced by butyric acid as completely as they did the apoptosis induced by anti-Fas antibody. These results suggest that caspase-8 and -9 are not necessarily the principal initiators that mediate butyric acidinduced T-cell apoptosis. Some factors other than caspase-8 and -9 may play an important role as the major executioner together with these caspases in butyric acid-induced T-cell apoptosis.
In conclusion, our data indicate that Fas-FasL interaction is not involved in butyric acid-induced apoptosis and that caspase-8 and -9-dependent apoptosis plays an important role in butyric acid-as well as Fas-induced apoptosis. The specific mechanisms by which butyric acid initiates the apoptosis signaling pathway is currently being investigated.
